{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T20:36:18Z","timestamp":1774038978743,"version":"3.50.1"},"reference-count":32,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,9,1]],"date-time":"2016-09-01T00:00:00Z","timestamp":1472688000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Toxicology Letters"],"published-print":{"date-parts":[[2016,9]]},"DOI":"10.1016\/j.toxlet.2016.06.012","type":"journal-article","created":{"date-parts":[[2016,6,19]],"date-time":"2016-06-19T01:30:21Z","timestamp":1466299821000},"page":"159-167","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"special_numbering":"C","title":["MicroRNA-21 is associated with fibrosis in a rat model of nonalcoholic steatohepatitis and serves as a plasma biomarker for fibrotic liver disease"],"prefix":"10.1016","volume":"258","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3248-2190","authenticated-orcid":false,"given":"Ayano","family":"Takeuchi-Yorimoto","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu","family":"Yamaura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masayuki","family":"Kanki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tetsuya","family":"Ide","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ayumi","family":"Nakata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takahisa","family":"Noto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masahiro","family":"Matsumoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.toxlet.2016.06.012_bib0005","doi-asserted-by":"crossref","first-page":"369","DOI":"10.2174\/157016105774329480","article-title":"Connective tissue remodeling: cross-talk between endothelins and matrix metalloproteinases","volume":"3","author":"Abraham","year":"2005","journal-title":"Curr. Vasc. Pharmacol."},{"key":"10.1016\/j.toxlet.2016.06.012_bib0010","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1016\/S0092-8674(01)00616-X","article-title":"microRNAs: tiny regulators with great potential","volume":"107","author":"Ambros","year":"2001","journal-title":"Cell"},{"key":"10.1016\/j.toxlet.2016.06.012_bib0015","doi-asserted-by":"crossref","first-page":"e0142661","DOI":"10.1371\/journal.pone.0142661","article-title":"Performance of serum microRNAs \u2212122, \u2212192 and \u221221 as biomarkers in patients with non-alcoholic steatohepatitis","volume":"10","author":"Becker","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.toxlet.2016.06.012_bib0020","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1053\/gast.1996.v110.pm8608892","article-title":"Expression of tissue inhibitor of metalloproteinases 1 and 2 is increased in fibrotic human liver","volume":"110","author":"Benyon","year":"1996","journal-title":"Gastroenterology"},{"key":"10.1016\/j.toxlet.2016.06.012_bib0025","first-page":"837","article-title":"Hepatic MicroRNA orchestra: a new diagnostic, prognostic and theranostic tool for hepatocarcinogenesis","volume":"14","author":"Boye","year":"2014","journal-title":"Mini Rev. Med. Chem."},{"key":"10.1016\/j.toxlet.2016.06.012_bib0030","doi-asserted-by":"crossref","first-page":"2467","DOI":"10.1111\/j.1572-0241.1999.01377.x","article-title":"Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions","volume":"94","author":"Brunt","year":"1999","journal-title":"Am. J. Gastroenterol."},{"key":"10.1016\/j.toxlet.2016.06.012_bib0035","doi-asserted-by":"crossref","first-page":"e0003965","DOI":"10.1371\/journal.pntd.0003965","article-title":"Circulating miRNAs: potential novel biomarkers for hepatopathology progression and diagnosis of schistosomiasis japonica in two murine models","volume":"9","author":"Cai","year":"2015","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.toxlet.2016.06.012_bib0040","doi-asserted-by":"crossref","first-page":"e23937","DOI":"10.1371\/journal.pone.0023937","article-title":"Circulating microRNAs in patients with chronic hepatitis C and non-alcoholic fatty liver disease","volume":"6","author":"Cermelli","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.toxlet.2016.06.012_bib0045","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1002\/hep.22569","article-title":"Nonalcoholic steatohepatitis is associated with altered hepatic MicroRNA expression","volume":"48","author":"Cheung","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.toxlet.2016.06.012_bib0050","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/s11901-014-0224-8","article-title":"Mechanisms of liver injury in non-alcoholic steatohepatitis","volume":"13","author":"Duwaerts","year":"2014","journal-title":"Curr. Hepatol. Rep."},{"key":"10.1016\/j.toxlet.2016.06.012_bib0055","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1136\/flgastro-2013-100403","article-title":"Non-alcoholic fatty liver disease: a practical approach to diagnosis and staging","volume":"5","author":"Dyson","year":"2014","journal-title":"Frontline Gastroenterol."},{"key":"10.1016\/j.toxlet.2016.06.012_bib0060","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1586\/17474124.2.6.803","article-title":"Advances in antifibrotic therapy","volume":"2","author":"Ghiassi-Nejad","year":"2008","journal-title":"Expert Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.toxlet.2016.06.012_bib0065","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1002\/hep.27671","article-title":"Recombinant adeno-associated virus-mediated inhibition of microRNA-21 protects mice against the lethal schistosome infection by repressing both IL-13 and transforming growth factor beta 1 pathways","volume":"61","author":"He","year":"2015","journal-title":"Hepatology"},{"key":"10.1016\/j.toxlet.2016.06.012_bib0070","first-page":"1647","article-title":"Tissue inhibitor of metalloproteinase-1 and -2 RNA expression in rat and human liver fibrosis","volume":"150","author":"Herbst","year":"1997","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.toxlet.2016.06.012_bib0075","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1002\/hep.510240129","article-title":"Tissue inhibitor of metalloproteinase-1 messenger RNA expression is enhanced relative to interstitial collagenase messenger RNA in experimental liver injury and fibrosis","volume":"24","author":"Iredale","year":"1996","journal-title":"Hepatology"},{"key":"10.1016\/j.toxlet.2016.06.012_bib0080","doi-asserted-by":"crossref","first-page":"15343","DOI":"10.3748\/wjg.v20.i41.15343","article-title":"Elevated miR-33a and miR-224 in steatotic chronic hepatitis C liver biopsies","volume":"20","author":"Lendvai","year":"2014","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.toxlet.2016.06.012_bib0085","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1038\/labinvest.2010.126","article-title":"Correlation between microRNA expression levels and clinical parameters associated with chronic hepatitis C viral infection in humans","volume":"90","author":"Marquez","year":"2010","journal-title":"Lab. Invest."},{"key":"10.1016\/j.toxlet.2016.06.012_bib0090","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1016\/S0016-5085(99)70506-8","article-title":"Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity","volume":"116","author":"Matteoni","year":"1999","journal-title":"Gastroenterology"},{"key":"10.1016\/j.toxlet.2016.06.012_bib0095","doi-asserted-by":"crossref","first-page":"10513","DOI":"10.1073\/pnas.0804549105","article-title":"Circulating microRNAs as stable blood-based markers for cancer detection","volume":"105","author":"Mitchell","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.toxlet.2016.06.012_bib0100","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.3390\/cancers6031220","article-title":"Fibrogenesis and carcinogenesis in nonalcoholic steatohepatitis (NASH): involvement of matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinase (TIMPs)","volume":"6","author":"Okazaki","year":"2014","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.toxlet.2016.06.012_bib0105","article-title":"Cytokine functions of TIMP-1","author":"Ries","year":"2013","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.toxlet.2016.06.012_bib0110","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.taap.2013.01.027","article-title":"Persistent fibrosis in the liver of choline-deficient and iron-supplemented L-amino acid-defined diet-induced nonalcoholic steatohepatitis rat due to continuing oxidative stress after choline supplementation","volume":"268","author":"Takeuchi-Yorimoto","year":"2013","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.toxlet.2016.06.012_bib0115","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1016\/S0140-6736(14)60121-5","article-title":"Liver cirrhosis","volume":"383","author":"Tsochatzis","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.toxlet.2016.06.012_bib0120","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1002\/hep.23100","article-title":"Role of microRNA-155 at early stages of hepatocarcinogenesis induced by choline-deficient and amino acid-defined diet in C57BL\/6 mice","volume":"50","author":"Wang","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.toxlet.2016.06.012_bib0125","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1007\/s12013-013-9539-2","article-title":"Effect of miR-21 on renal fibrosis by regulating MMP-9 and TIMP1 in kk-ay diabetic nephropathy mice","volume":"67","author":"Wang","year":"2013","journal-title":"Cell Biochem. Biophys."},{"key":"10.1016\/j.toxlet.2016.06.012_bib0130","doi-asserted-by":"crossref","DOI":"10.2217\/bmm.15.70","article-title":"Molecular regulation of miRNAs and potential biomarkers in the progression of hepatic steatosis to NASH","author":"Wang","year":"2015","journal-title":"Biomark. Med."},{"key":"10.1016\/j.toxlet.2016.06.012_bib0135","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.biopha.2013.03.014","article-title":"MicroRNA-21 activates hepatic stellate cells via PTEN\/Akt signaling","volume":"67","author":"Wei","year":"2013","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.toxlet.2016.06.012_bib0140","article-title":"MicroRNA-21 is a potential link between non-alcoholic fatty liver disease and hepatocellular carcinoma via modulation of the HBP1-p53-Srebp1c pathway","author":"Wu","year":"2015","journal-title":"Gut"},{"key":"10.1016\/j.toxlet.2016.06.012_bib0145","doi-asserted-by":"crossref","first-page":"3621","DOI":"10.3748\/wjg.v10.i24.3621","article-title":"Dynamic changes in the expression of matrix metalloproteinases and their inhibitors, TIMPs, during hepatic fibrosis induced by alcohol in rats","volume":"10","author":"Xu","year":"2004","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.toxlet.2016.06.012_bib0150","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1148\/radiol.14132000","article-title":"Hepatic fibrosis: prospective comparison of MR elastography and US shear-wave elastography for evaluation","volume":"273","author":"Yoon","year":"2014","journal-title":"Radiology"},{"key":"10.1016\/j.toxlet.2016.06.012_bib0155","doi-asserted-by":"crossref","first-page":"37082","DOI":"10.1074\/jbc.M113.517953","article-title":"The autoregulatory feedback loop of microRNA-21\/Programmed cell death protein 4\/Activation protein-1 (MiR-21\/PDCD4\/AP-1) as a driving force for hepatic fibrosis development","volume":"288","author":"Zhang","year":"2013","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.toxlet.2016.06.012_bib0160","doi-asserted-by":"crossref","first-page":"e108005","DOI":"10.1371\/journal.pone.0108005","article-title":"MiR-21 simultaneously regulates ERK1 signaling in HSC activation and hepatocyte EMT in hepatic fibrosis","volume":"9","author":"Zhao","year":"2014","journal-title":"PLoS One"}],"container-title":["Toxicology Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378427416301527?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378427416301527?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,11]],"date-time":"2018-09-11T00:23:56Z","timestamp":1536625436000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0378427416301527"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9]]},"references-count":32,"alternative-id":["S0378427416301527"],"URL":"https:\/\/doi.org\/10.1016\/j.toxlet.2016.06.012","relation":{},"ISSN":["0378-4274"],"issn-type":[{"value":"0378-4274","type":"print"}],"subject":[],"published":{"date-parts":[[2016,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"MicroRNA-21 is associated with fibrosis in a rat model of nonalcoholic steatohepatitis and serves as a plasma biomarker for fibrotic liver disease","name":"articletitle","label":"Article Title"},{"value":"Toxicology Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.toxlet.2016.06.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}